Democracy International Fund (NYSEARCA:DMCY – Get Free Report)’s share price fell 1.6% on Wednesday . The stock traded as low as $22.18 and last traded at $22.18. 1,187 shares were traded during mid-day trading, a decline of 8% from the average session volume of 1,287 shares. The stock had previously closed at $22.54.
Democracy International Fund Price Performance
The stock has a market cap of $6.65 million, a P/E ratio of 11.52 and a beta of 0.84. The firm’s fifty day moving average price is $22.93 and its two-hundred day moving average price is $23.42.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in DMCY. Citadel Advisors LLC bought a new position in Democracy International Fund in the second quarter valued at $532,000. GTS Securities LLC bought a new position in Democracy International Fund in the second quarter valued at $346,000. Jane Street Group LLC bought a new position in Democracy International Fund in the third quarter valued at $251,000. Flow Traders U.S. LLC bought a new position in Democracy International Fund in the second quarter valued at $296,000. Finally, Parallel Advisors LLC increased its stake in Democracy International Fund by 21.0% in the second quarter. Parallel Advisors LLC now owns 17,331 shares of the company’s stock valued at $411,000 after acquiring an additional 3,003 shares during the last quarter.
Democracy International Fund Company Profile
The Democracy International Fund (DMCY) is an exchange-traded fund that is based on the Democracy Investments International index. The fund tracks an index of global, large- and mid-cap companies outside the US. The index aims to overweight investments in democratic countries while underweighting those in authoritarian countries.
Featured Articles
- Five stocks we like better than Democracy International Fund
- Dividend Payout Ratio Calculator
- Dollar Tree Won’t Be Trading At a Discount For Much Longer
- Your Comprehensive Guide to Investing in Bank Stocks
- ASML Holding is a Great Buy but at a Cheaper Price
- How to Invest in Pharmaceutical Companies
- Oversold and Overextended, Abbott Laboratories is a Great Buy
Receive News & Ratings for Democracy International Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Democracy International Fund and related companies with MarketBeat.com's FREE daily email newsletter.
